Healthcare M&A and Valuation
News and Insights

The ambulatory surgery center (ASC) industry has experienced significant growth over the past decade, driven by the shift toward...

The dermatology industry is a fast-growing sector within the broader healthcare market, driven by increasing demand for both medical and cosmetic dermatological services, as well as service line expansion into aesthetic dermatology and the med spa / wellness category. Medical dermatology focuses on the diagnosis and treatment of skin conditions such as acne, eczema, psoriasis, and skin cancer, while cosmetic dermatology includes procedures like Botox, fillers, laser treatment

The diagnostic imaging center industry is a critical component of the healthcare sector, providing essential services for the detection, diagnosis, and monitoring of various medical conditions. These facilities utilize advanced imaging technologies such as X-rays, Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Ultrasound, and Positron Emission Tomography (PET) to produce detailed images of the body’s internal structures. The industry has seen significant growth o

On June 2, 2025, Ascension Health Alliance, one of the largest nonprofit Catholic health systems in the U.S., entered into a definitive agreement to acquire AmSurg, a leading ambulatory surgery center (ASC) developer, manager and operator that owns and partners with more than 250 outpatient surgery centers across 34 states. The all‑cash transaction, reported by multiple industry sources at approximately $3.9 billion in enterprise value, will significantly expand Ascension’s

On May 30, 2025, The Graph Group , a New Jersey-based healthcare investment firm, announced the acquisition of the acute and intermediate behavioral health services division of Seaside Health System of Baton Rouge , a long-standing inpatient psychiatric provider in Louisiana. Seaside Health System, part of the broader Seaside Healthcare platform backed by Pharos Capital Group, operates a licensed psychiatric facility offering 24/7 inpatient psychiatric stabilization and part

On May 28, 2025, global alternative asset manager Brookfield Asset Management, alongside Caisse de dépôt et placement du Québec (CDPQ), announced the acquisition of GTCR’s Antylia Scientific, a U.S.-based integrated provider of scientific research tools, laboratory services and specialty instruments serving biopharma, diagnostics and academic markets. Antylia’s platform combines branded products, custom solutions, and technical services that address complex laboratory needs

The infusion therapy market has experienced significant growth in recent years, driven by the increasing prevalence of chronic diseases,...

The addiction treatment industry is a vital and rapidly evolving segment of the behavioral healthcare market, focused on the diagnosis and treatment of substance use disorders (SUDs), including alcohol, opioids, stimulants, and other drugs. Services range from detoxification and inpatient rehabilitation to outpatient therapy and medication-assisted treatment (MAT). Key Growth Drivers Key growth drivers for the industry include the following: Rising Prevalence of Substance Abu

On April 21, 2025, Concentra Group Holdings Parent, Inc. (NYSE: CON), the nation’s largest provider of occupational health services, announced the acquisition of Pivot Onsite Innovations, a leading provider of employer‑based onsite health clinics, from Athletico Physical Therapy for approximately $55 million in cash and assumed adjustments. Pivot operates over 200 onsite health clinics at employer locations across more than 40 states, offering occupational health, wellness,

On April 15, 2025, Ascension Health, one of the largest nonprofit health systems in the United States, announced the acquisition of Cedar Park Regional Medical Center, a full-service acute care hospital in Texas formerly owned by Community Health Systems (CHS). Cedar Park serves a rapidly growing suburban population with comprehensive inpatient and outpatient care, including emergency services, surgical care, women’s health, and specialist physician services. For Ascension,

In March 2025, Roper Technologies announced the acquisition of Insight Partners’ CentralReach, a leading provider of web-based practice management, clinical, and data solutions for Applied Behavior Analysis (ABA) therapy and other developmental disability services. CentralReach’s integrated platform supports care providers with electronic health records (EHR), billing and scheduling, outcomes tracking, and reporting tools tailored to behavioral health and therapy practices,

On March 11, 2025, Better Choice Company, Inc. (NYSE American: BTTR) signed a binding Letter of Intent to acquire 100 % of Choice Specialty Pharmacy Group, a fully licensed U.S. provider of specialty pharmacy and infusion clinic services with an integrated sterile compounding facility, under an option purchase agreement. The transaction, which is expected to close later in 2025 following exercise of the option, strengthens Better Choice’s footprint in healthcare services alo